US20140263062A1 - Universal portable machine for online hemodiafiltration using regenerated dialysate - Google Patents

Universal portable machine for online hemodiafiltration using regenerated dialysate Download PDF

Info

Publication number
US20140263062A1
US20140263062A1 US13/828,240 US201313828240A US2014263062A1 US 20140263062 A1 US20140263062 A1 US 20140263062A1 US 201313828240 A US201313828240 A US 201313828240A US 2014263062 A1 US2014263062 A1 US 2014263062A1
Authority
US
United States
Prior art keywords
flow
dialysate
manifold
method
circuit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/828,240
Inventor
Palmer David Updyke
Barry Fulkerson
Amaury De Leon De Leon
Michelle Bayly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Holdings Inc
Original Assignee
Fresenius Medical Care Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Holdings Inc filed Critical Fresenius Medical Care Holdings Inc
Priority to US13/828,240 priority Critical patent/US20140263062A1/en
Assigned to FRESENIUS MEDICAL CARE HOLDINGS, INC. reassignment FRESENIUS MEDICAL CARE HOLDINGS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYLY, MICHELLE, DE LEON DE LEON, AMAURY, FULKERSON, BARRY, UPDYKE, PALMER DAVID
Publication of US20140263062A1 publication Critical patent/US20140263062A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3663Flow rate transducers; Flow integrators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
    • A61M1/1621Constructional aspects thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
    • A61M1/1694Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes with recirculating dialysing liquid
    • A61M1/1696Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes with recirculating dialysing liquid with dialysate regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/3413Diafiltration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3455Substitution fluids
    • A61M1/3465Substitution fluids using dialysate as substitution fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424Substitution fluid path
    • A61M1/3431Substitution fluid path upstream the filter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/12General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/75General characteristics of the apparatus with filters
    • A61M2205/7518General characteristics of the apparatus with filters bacterial

Abstract

Manifolds suitable for use in hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis are provided. One or more of the manifolds can include a manifold body and an external tube. The manifold body can include at least one conduit including a first conduit and at least one port including a first port in fluid communication with the first conduit. The external tube can be in fluid communication with the first port and can include a main segment, a first branch segment, and a second branch segment containing at least one bacterial filter. The first branch segment and/or second branch segment can include at least one flow restrictor. Dialysis machines, systems, and kits including one or more such manifold are also provided, as are methods of performing hemodiafiltration using such manifolds.

Description

    FIELD
  • The present invention relates to materials, machines, systems, and methods for conducting hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis.
  • BACKGROUND OF THE INVENTION
  • In hemofiltration (HF), solute clearance is achieved through convection, that is, solutes are pulled, along with water, down a pressure gradient. Hemodiafiltration (HDF) combines the concentration-based diffusion of hemodialysis (HD) with hemofiltration. HF generally provides better removal of large molecular weight solutes, improved clearance of low molecular weight uremic toxins, and better cardiovascular stability and blood pressure control than HD. HF can be especially beneficial to long term dialysis patients who are likely to be on dialysis for a long time, and for larger patients in whom it is not possible to achieve sufficient Kt/V with HD. Intradialytic symptoms are often reduced with HF, and residual renal function can be better preserved with HDF. HDF also appears to have beneficial effects on mortality and hospitalization.
  • The ultrafiltration (UF) aspect of HDF results in loss of fluid. This fluid loss can be made up with replacement fluid, which should be ultrapure, with minimal contamination, because the fluid is placed directly into the blood stream. The reliance on ultrapure water has limited the portability of HDF systems. It would be desirable to have a machine that would minimize the amount of water or bagged fluid that is currently used for HDF. The use of highly permeable and high flux membranes, high blood flows, and accurate control of volume replacement also make HDF a complicated undertaking. Accordingly, there exists a need for better materials and methods for conducting HDF.
  • SUMMARY OF THE PRESENT INVENTION
  • A feature of the present invention is to provide materials and methods for performing hemodiafiltration, as well as hemodialysis, hemofiltration, and peritoneal dialysis.
  • Another feature of the present invention is to utilize purified dialysate as replacement (ultrafiltration) fluid into the bloodstream to minimize or avoid the use of dedicated, ultrapure replacement fluid, or reliance on additional, cumbersome water purification systems.
  • Yet another feature of the present invention is to provide a more portable hemodiafiltration system.
  • Additional features and advantages of the present invention will be set forth in part in the description that follows, and in part will be apparent from the description, or may be learned by practice of the present invention. The objectives and other advantages of the present invention will be realized and attained by means of the elements and combinations particularly pointed out in the description and appended claims.
  • To achieve these and other advantages, and in accordance with the purposes of the present invention, as embodied and broadly described herein, a manifold suitable for use in hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis, is provided. The manifold can include a manifold body and an external tube. For example, the manifold can include a manifold body, at least one pump tube including a first pump tube, and at least one external tube including a first external tube. The manifold body can include at least one conduit including a first conduit and at least one port including a first port in fluid communication with the first conduit. The external tube can be in fluid communication with the first port and can include a main segment, a first branch segment, and a second branch segment containing at least one bacterial filter. The first branch segment and/or second branch segment can include at least one flow restrictor. The second branch segment can contain any number or type of bacterial filters.
  • In accordance with the present invention, a dialysis machine is provided that can include a housing, a receptacle mounted on the housing and configured to accept a manifold, a manifold operatively engaged with the receptacle, and at least one flow restrictor mounted on the housing and configured for accepting at least one of the first branch segment and the second branch segment of the manifold. The at least one flow restrictor can include a first flow restrictor configured to accept the first branch segment and a second flow restrictor configured for accepting the second branch segment. The at least one flow restrictor can include a static flow restrictor, a dynamic (variable) flow restrictor, or both.
  • A kit including the manifold is also provided. The kit can further include a dialyzer, tubing, a bacterial filter, and other components suitable for hemodialysis, hemofiltration, hemodiafiltration, and/or peritoneal dialysis. The present invention also provides a dialysis system, and the dialysis system can include a dialysis machine, a manifold operatively engaged with the dialysis machine, and a supply of dialysate in fluid communication with the manifold. The dialysis system can be configured to perform one or more of hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis.
  • In accordance with the present invention, a method of performing hemodiafiltration on a patient, is provided. The method can include one or more of the following steps. A flow of dialysate can be pumped through a dialysate circuit. A flow of blood can be pumped through an extracorporeal blood circuit. The flow of dialysate in the dialysate circuit can be restricted to divert a portion of the flow of dialysate into the extracorporeal blood circuit. The portion can be passed through the at least one bacterial filter before the portion enters the blood circuit. The flow restriction can be static, varied, or both.
  • It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are intended to provide a further explanation of the present invention, while not limiting the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated in and constitute a part of this application, illustrate some of the embodiments of the present invention. The drawings, together with the description, serve to explain the principles of the present invention.
  • FIG. 1 is a front view of a dialysis system in accordance with the present invention.
  • FIG. 2 is a right perspective view a dialysis system in accordance with the present invention, showing the modularity of the system.
  • FIG. 3 is a left view of a dialysis system in accordance with the present invention, with the door open to show a manifold engaged with the system.
  • FIG. 4 is a front view of a manifold in accordance with the present invention.
  • FIG. 5 is a left, perspective, close-up view of a dialysis system in accordance with the present invention, with the door open.
  • FIG. 6 is a schematic circuit diagram of a hemodialysis system in accordance with the present invention.
  • FIG. 7A is a schematic circuit diagram of a hemodiafiltration system in accordance with the present invention.
  • FIG. 7B is an enlargement of a portion of the hemodiafiltration system shown in FIG. 7A.
  • FIG. 8 is a schematic flow diagram of the schematic circuit diagram shown in FIG. 7A.
  • DETAILED DESCRIPTION OF THE PRESENT INVENTION
  • In accordance with the present invention, a manifold suitable for use in hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis is provided. The manifold can include a manifold body and an external tube. The manifold body can include at least one conduit including a first conduit, and at least one port including a first port in fluid communication with the first conduit. The external tube can be in fluid communication with the first port and can include a main segment, a first branch segment, and a second branch segment including at least one bacterial filter. Any number or type of bacterial filters can be used. For example, the second branch segment can include at least two bacterial filters.
  • The manifold including the external tube can contain any number or type of flow restrictor and/or be restricted by one or more external flow restrictors. For example, at least one of the first branch segment and the second branch segment can contain a flow restrictor. The first branch segment can include a first flow restrictor and the second branch segment can include a second flow restrictor. The second flow restrictor can be located between the at least one bacterial filter and the main segment. The flow restrictor can be a static flow restrictor, a variable flow restrictor, or a combination thereof. One or more valve can act as a flow restrictor. Examples of flow restrictors that can be used include those described in U.S. Pat. Nos. 4,037,596, 4,267,834, 4,464,179, 4,626,243, 5,248,300, 5,282,981, 5,409,477, U.S. Pat. No. 6,655,207 B1, U.S. Pat. No. 6,892,755 B2, U.S. Pat. No. 7,018,327 B1, U.S. Pat. No. 7,631,562 B1, and U.S. Pat. No. 7,690,396 B2, which are incorporated herein by reference in their entireties. Examples of flow restrictors that can be used also include those described in U.S. Patent Application Publications Nos. US 2004/0116905 A1, US 2007/0131296 A1, US 2008/0017260 A1, US 2008/0029173 A1, US 2012/0190919 A1, US 2012/0265164 A1, and US 2012/0266965 A1, which are also incorporated herein by reference in their entireties.
  • The manifold can be configured to engage a dialysis machine and the first conduit can be configured to join a first circuit. The dialysis machine can have at least one pump and the manifold can be configured to engage the at least one pump to allow for a movement of a first fluid in the first circuit. The at least one pump can include any desired type of pump, for example, a peristaltic pump. The manifold can include a second conduit and be configured to join a second circuit. The dialysis machine can have a second pump and the manifold can be configured to engage the second pump to allow for movement of a second fluid in the second circuit. The external tube can be in fluid communication with the first and second conduits. The second branch segment can contain a valve between the at least one bacterial filter and the main segment. The first circuit can be a dialysate circuit and the second circuit can be an extracorporeal blood circuit, or vice versa. The manifold can further include a dialyzer in fluid communication with the first branch segment. The dialyzer can be separate from the manifold body.
  • In accordance with the present invention, a dialysis machine is provided that can include a housing, a receptacle mounted on the housing and configured to accept a manifold of the present invention, a manifold of the present invention operatively engaged with the receptacle, and at least one flow restrictor mounted on the housing and configured for accepting at least one of the first branch segment and the second branch segment of the manifold. The at least one flow restrictor can include a first flow restrictor configured to accept the first branch segment and a second flow restrictor configured for accepting the second branch segment. The at least one flow restrictor can include a static flow restrictor, a dynamic (variable) flow restrictor, or both.
  • A kit including the manifold as described herein, is also provided. The kit can further include a dialyzer, tubing, a bacterial filter, and other components suitable for hemodialysis, hemofiltration, hemodiafiltration, and/or peritoneal dialysis. The components can be preassembled (connected), separate, or partially connected, in the kit. Components can be coded using, for example, colors, letters, numbers, barcodes, RFID tags, or a combination thereof, to aid in the assembly of the components and installation on a dialysis machine to form a dialysis system. One or more components of the kit can be disposable and/or reusable. In some cases, the entire kit can comprise disposable components.
  • The present invention also provides a dialysis system. The dialysis system can include a dialysis machine, and a manifold operatively engaged with the dialysis machine. A supply of dialysate can be provided in fluid communication with the manifold. The dialysis system can be configured to perform one or more of hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis.
  • In accordance with the present invention, a manifold is provided that is suitable for use in one or more of hemodialysis, hemofiltration, hemodiafiltration, and peritoneal dialysis. Kits, machines, and systems including the manifold are also provided. The manifold can include a manifold body, at least one pump tube including a first pump tube, and at least one external tube including a first external tube. The manifold body can comprise a first transom having a first edge, and second and third edges that are substantially parallel to the first edge. The manifold can comprise a trunk that is substantially perpendicular to and adjacent the first transom, and a second transom. The second transom can be substantially perpendicular to and adjacent the trunk, and substantially parallel to the first transom. The second transom can include a fourth edge, and fifth and sixth edges that are substantially parallel to the first, second, and third edges. The manifold can contain one or more ports. For example, a plurality of ports that can be arrayed along the fourth edge. The plurality of ports can include at least a first port and a second port. A third port can be located on the second edge, and a fourth port can be located on the fifth edge. A first conduit can be located in the second transom in fluid communication with the first and fourth ports. A second conduit can be located in the first transom and in fluid communication with the second and third ports. The first pump tube can be in fluid communication with the third and fourth ports.
  • The first external tube of the manifold can be in fluid communication with the second port. The first external tube can include a main segment, a first branch segment, and a second branch segment. At least one of the first branch segment and the second branch segment can contain a flow restrictor. The first branch segment can contain a first flow restrictor and the second branch segment can contain a second flow restrictor. The second flow restrictor can be located between the at least one bacterial filter and the main segment. The flow restrictor can include a static flow restrictor, a dynamic flow restrictor, or both. The second branch segment can include at least one bacterial filter. The second branch segment can include a valve between the at least one bacterial filter and the main segment. The manifold can further include a dialyzer in fluid communication with the first branch segment. The dialyzer can be separate from the manifold body.
  • The manifold can be configured to engage a dialysis machine and the first conduit can be configured to join a first circuit. The dialysis machine can have at least one pump and the manifold can be configured to engage the at least one pump with the first pump tube to allow for a movement of a first fluid in the first circuit. The at least one pump can be any desired type of pump, for example, a peristaltic pump. The manifold can include a second pump tube in fluid communication with a fifth port on the second edge and a sixth port on the fifth edge, and the second pump tube can be configured to join a second circuit. The dialysis machine can have a second pump and the manifold can be configured to engage the second pump with the second pump tube to allow for movement of a second fluid in the second circuit. The external tube of the manifold can be in fluid communication with the first and second circuits. The first circuit can be a dialysate circuit and the second circuit can be an extracorporeal blood circuit, or vice versa.
  • In accordance with the present invention, a method of performing hemodiafiltration on a patient is provided. The method can include one or more of the following steps. A flow of dialysate can be pumped through a dialysate circuit. A flow of blood can be pumped through an extracorporeal blood circuit. The flow of dialysate in the dialysate circuit can be restricted to divert a portion of the flow of dialysate into the extracorporeal blood circuit. The portion can be passed through the at least one bacterial filter before the portion enters the blood circuit. The flow restriction can be static, varied, or both.
  • The dialysate circuit used in the circuit can include a branched conduit containing a main segment, a first branch segment, and a second branch segment. The second branch segment can carry the portion and be in fluid communication with the extracorporeal blood circuit. The restricting can include restricting the flow of dialysate in at least one of the first branch segment and the second branch segment. The restricting can include restricting the flow of dialysate in both the first branch segment and the second branch segment.
  • At least one of the flow of dialysate and the flow of blood can be pumped through a manifold engaged with a dialysis machine. The method can include engaging the manifold with the dialysis machine. At least one of pumping the flow of dialysate and pumping the flow of blood can include the use of at least one peristaltic pump. The dialysate circuit used in the method can contain a sorbent cartridge capable of regenerating the dialysate. The method can include pumping an electrolyte solution into the dialysate circuit. The pumping of the flow of dialysate and the pumping of the flow of blood can include pumping through at least one dialyzer.
  • The bacterial filter used in the method can include at least one dialyzer. For example, any of the bacterial filters described in U.S. Pat. Nos. 4,311,587, 4,347,136, 4,568,366, 5,868,933, U.S. Pat. No. 6,565,749 B2, U.S. Pat. No. 6,989,101 B2, U.S. Pat. No. 7,303,683 B2, U.S. Pat. No. 7,614,506 B2, U.S. Pat. No. 7,615,152 B2, and U.S. Pat. No. 7,922,008 B2 can be used, and all of these patents are incorporated herein by reference in their entireties. The bacterial filters described in U.S. Patent Application Publications Nos. US 2001/0037964 A1, US 2003/0000884 A1, US 2003/0098276 A1, US 2004/0164006, US 2005/0000883 A1, US 2007/0278141 A1, US 2008/0164214 A1, and US 2009/0188854 A1 can be used, and all of these publications are incorporated herein by reference in their entireties.
  • A dialyzer can be chosen from any suitable dialyzer compatible with the present methods, manifolds, machines, and systems of the present invention. A polysulfone dialyzer can be used. For example, the dialyzer can be an F180PSD, an F180NRE, an Optiflux®, a Hemaflow™, or an Ultraflux dialyzer available from Fresenius Medical Care North America, Waltham, Mass. The dialyzers described in U.S. Pat. Nos. 4,141,836, 4,172,794, 4,261,830, 5,882,516, U.S. Pat. No. 6,802,821 B2, U.S. Pat. No. 6,911,007 B2, U.S. Pat. No. 8,202,428 B2, and U.S. Pat. No. 8,303,807 B2 can be used, all of which patents are incorporated herein by reference in their entireties. The dialyzers described in U.S. Patent Application Publications Nos. US 2005/0236330 A1, US 2009/007862 A1, US 2009/0223880 A1, US 2012/0172736 A1, and US 2013/0004593 A1 can be used, and all of these publications are incorporated herein by reference in their entireties. An ion-rejecting dialyzer membrane can be used, which can reduce or eliminate the need for added electrolytes and, accordingly, increase portability.
  • A sorbent cartridge for use in the present invention can contain one or more of activated carbon, urease, zirconium phosphate, zirconium carbonate, and zirconium oxide. Any suitable sorbent cartridge can be used. For example, a HISORB®orHISORB®+ sorbent cartridge available from Renal Solutions, Inc. of Warrendale, Pa. can be used. The sorbents and sorbent cartridges described in U.S. Pat. Nos. 3,989,622, 4,190,047, 4,213,859, 4,247,393, 4,661,246, 5,277,820, 5,536,412, 5,919,369, 5,944,684, U.S. Pat. No. 6,348,162 B1, U.S. Pat. No. 6,960,179 B2, U.S. Pat. No. 7,033,498 B2, U.S. Pat. No. 7,169,303 B2, U.S. Pat. No. 7,208,092 B2, U.S. Pat. No. 7,736,507 B2, U.S. Pat. No. 7,867,214 B2, U.S. Pat. No. 7,922,686 B2, U.S. Pat. No. 7,922,911 B2, B2, U.S. Pat. No. 8,080,161 B2, U.S. Pat. No. 8,096,969 B2, U.S. Pat. No. 8,105,487 B2, U.S. Pat. No. 8,187,250 B2, U.S. Pat. No. 8,220,643 B2, and U.S. Pat. No. 8,357,113 B2 can be used, and all of these patents are incorporated herein by reference in their entireties. Sorbents and sorbent cartridges described in U.S. Patent Application Publications Nos. US 2002/0112609 A1, US 20030097086 A1, US 20030114787 A1, US 2004/0019312 A1, US 2004/0019320 A1, US 2004/0050789 A1, US 2004/0082903 A1, US 2005/0006296 A1, US 2005/0131332 A1, US 2007/0158267 A1, US 2007/0179431 A1, US 2007/0213665 A1, US 2009/0120864 A1, US 2009/0127193 A1, US 2009/0264812 A1, US 2009/0314707 A1, US 2010/0010429 A1, US 2010/0010430 A1, US 2010/0078387 A1, US 2010/0100027 A1, US 2010/0114012 A1, US 2010/0217181 A1, US 2010/0230346 A1, US 2010/0312172 A1, US 2010/0312174 A1, US 2010/0314314 A1, US 2011/0017665 A1, US 2011/0155667 A1, US 2011/0171713 A1, US 2011/0184340 A1, US 2011/0272337 A1, US 20110297593 A1, US 2011/0303588 A1, US 2011/0303590 A1, US 20120248017 A1, US 2011/0315611 A1, US A1, US 2012/0271227 A1, or US 2013/0008852 A1 can be used, and all of these publications are incorporated herein by reference in their entireties. Dialysis regeneration can be achieved using other techniques instead of, or in addition to, sorbent-based techniques, to remove toxins or other species. For example, electrodialysis can be used as described in U.S. Patent Application Publications Nos. US 2012/0273354 A1 and US 2012/0220926 A1, which are incorporated herein by reference in their entireties.
  • U.S. Patent Application Publication Nos. US 2012/0280154 A1 and US 2010/0179464 A1, which are incorporated herein by reference in their entireties, describe valves and other elements that can be used in accordance with the present invention. US 2012/0204968 A1, which is incorporated herein by reference in its entirety, describes priming methods and other elements that can be used in accordance with the present invention. US 2012/0103885 A1, US 2012/0090706 A1, US 2010/0116740 A1, and US 2009/0173682 A1, which are incorporated herein by reference in their entireties, describe manifolds, ultrafiltration control means, and other elements that can be used in accordance with the present invention. US 2010/0331754 A1, 2009/0101577 A1, and US 2009/0076434 A1, which are incorporated herein by reference in their entireties, describe pressure measurements, volume control, ultrafiltration control, and other elements that can be used in accordance with the present invention. US 2010/0252490 A1, which is incorporated herein by reference in its entirety, describes a dialysate reservoir and other elements that can be used in accordance with the present invention. US 2010/0234786 A1, which is incorporated herein by reference in its entirety, describes a disconnection monitor and other elements that can be used in accordance with the present invention. US 2010/0184198 A1, which is incorporated herein by reference in its entirety, describes a method of ammonia removal and other elements that can be used in accordance with the present invention. US 2011/0315611 A1, US 2011/0054378 A1, US 2010/0140149 A1, and US 2009/0101552 A1, which are incorporated herein by reference in their entireties, describe a manifold, dialysis machine, dialysis system, and other elements that can be used in accordance with the present invention. US 2012/0073365 A1, US 2010/0116048 A1, and US 2009/0114037 A1, which are incorporated herein by reference in their entireties, describe flow meters and other elements that can be used in accordance with the present invention.
  • The extracorporeal circuit used in the method can include an arterial side and a venous side and the portion can be diverted into at least one of the arterial side and the venous side. The method can include measuring a central venous pressure of the patient. The flow restriction can be varied depending on the central venous pressure measured. The method can include determining a target volume of fluid to be added or removed from the patient. The flow restriction can be varied to add or remove the target volume. Blood can be pumped from the patient through the arterial line and through the tube section of the manifold and through the dialyzer back through the manifold and back to the patient. An initial supply of dialysate can be pumped to the manifold through an internal manifold passageway and tube section in operative communication with a tube section of the manifold.
  • In the present invention, a dialysis machine can perform a continuous hemofiltration (CHF) dialysis treatment utilizing the removed ultrafiltrate and initial small volume prime solution contained in a dialysis reservoir for the injection quality fluid used to provide the HDF treatment, thereby eliminating the need for additional fresh water or bagged solutions. For example, flow restrictors can be used to divert a portion of the dialysate flow through additional bacteria filters to the blood stream either pre or post dialyzer. For this closed system, the solution reaching the reservoir can be equal to both the dialysate flow and the HDF infused flow. Adjustments can be made by the dialysate pumps to accommodate for net ultrafiltration from the patient. Given that the initial prime volume can be small and no additional fluid needs to enter the system, the additional bacteria filters used for the injection (arterial and/or venous) side of the circuit can be minimal.
  • The present invention can use manifolds, disposables, dialysis machines, dialysis systems, methods or any other aspect of dialysis as described in U.S. Patent Application Publications Nos. US 2012/0280154 A1, US 2012/0204968 A1, US 2012/0103885 A1, US 2012/0090706 A1, US 2012/0073365 A1, US 2011/0315611 A1, US 2011/0054378 A1, US 2010/0331754 A1, US 2010/0252490 A1, US 2010/234786 A1, US 2010/0184198 A1, US 2010/0179464 A1, US 2010/0140149 A1, US 2010/0116740 A1, US 2010/0116048 A1, US 2009/0173682 A1, US 2009/0114037 A1, US 2009/0101577 A1, US 2009/0101552 A1, and US 2009/0076434 A1, each of which is incorporated herein by reference in its entirety.
  • Referring to FIGS. 1, 2, and 3, the dialysis system 100, 200 includes a top unit 101, 201 that is detachably affixed to a base 102, 202. Base unit 102, 202 contains a reservoir 122, 222 for fluid storage, measurement, and monitoring. Top unit 101, 201, also referred to as the main unit or controller unit, includes a graphical user interface 114, 214, a pumping unit, and a door 110, 210 having a power lock. To a first side of top unit 101, 201, is a clasp 105 used to detachably affix a dialyzer 103, 313. Also to a side of top unit 101, 201, is a sorbent cartridge locking base 104, 204, 318, that is used to detachably affix a sorbent cartridge 107, 317. Clasp 105, hemofilter 103, 315, sorbent cartridge locking base 104, 204, 318 and sorbent cartridge 107, 317 can be positioned on the same side of top unit 101, as shown in FIG. 3, or on different sides or at different positions. In either case, base unit 102, 202, 302 can have a sufficiently larger top surface area relative to the top unit such that shelves can be formed on either side of the top unit to hold the sorbent cartridge, to hold an infusate jar, to capture any spillage, and/or to channel any leaks into a leak detector. With reference to FIG. 3, a door 319 is shown in an open position to reveal a manifold 320 mounted to the top unit 301. A handle 311 can be provided on top unit 301. The system configurations shown in FIGS. 1, 2, and 3 are exemplary and not limiting. For example, as shown in FIG. 3, top unit 301 can be positioned on one side of base unit 302, as opposed to being centrally positioned on top of base unit 302. Further details of suitable dialysis machines and components thereof, which can be used to carry out the methods of the present invention and form the systems of the present invention, are described, for example, in U.S. Patent Application Publication No. US 2011/0315611 A1, which is incorporated herein by reference in its entirety.
  • With reference to FIG. 4, a manifold 410 can be provided that has a capital I-shaped body 412. Manifold body 412 can include a first transom 414 and a second transom 416 that are joined together by a central member or trunk 418. Both transoms can have first and second arms located on either side of trunk, for example, a first arm 420 can be on a left side of transom 414 and a second arm 422 can be on the right side of transom 414. Similarly, third and fourth arms 424, 426 can be on respective sides of second transom 416. First transom 414 can have first, second, and third edges 428, 430, and 432, respectively. First edge 428 spans first transom 414, and second edge 430 and third edge 432 are along first arm 420 and second arm 422, respectively. Second transom 416 can have fourth, fifth, and sixth edges, 434, 436, and 438, respectively. Fourth edge 434 spans second transom 416, and fifth edge 436 and sixth edge 438 are along third arm 424 and fourth arm 426, respectively.
  • Various conduits can be located in manifold body 412 and can be in fluid communication with valves, pressure sensor chambers, and other elements within manifold body 412 as well as being in fluid communication with one or more manifold ports on manifold body 412. The manifold ports can include intra-manifold ports and external ports. The intra-manifold ports can be joined by one or more pumping tube, and the external ports can fluidly connect the manifold to other portions of the dialysis machine and to the patient, via tubes. The tubes can be flexible. A flexible membrane or sheet can cover part of one or more sides of the manifold and can form part of the manifold body.
  • As depicted in FIG. 4, the external ports can be lettered from “A” to “M” (omitting “I”). The intra-manifold ports can be referred to by ordinal numbers, for example, 440, 442, 444, 446, 448, 450, 452, and 454. External ports A and B are shown along first edge 428 of first transom 414 and external ports C through M are arrayed along fourth edge 434 of second transom 416. First and second intra-manifold ports 440, 442 are arrayed along second edge 430 of first arm 420. Third and fourth intra-manifold ports 444, 446 are arrayed along third edge 432 of second arm 422. Fifth and sixth intra-manifold ports 448, 450 are arrayed along fifth edge 436 of third arm 424, and seventh and eighth intra-manifold ports 452, 454 are arrayed along sixth edge 438 of fourth arm 426. A first pumping tube 456 joins first and fifth intra-manifold ports 440, 448, respectively. A second pumping tube 458 joins second and sixth intra-manifold ports, 442, 450, respectively. A third pumping tube 460 joins third and seventh intra-manifold ports, 444, 452, fourth pumping tube 462 joins the fourth and eighth intra-manifold ports 446, 454, respectively.
  • A first conduit 464 can extend from external port A to first intra-manifold port 440 and can contain a first pressure sensor chamber 466. A second conduit 468 can extend from fifth intra-manifold port 448 to external port C. A third conduit 470 can branch off of second conduit 468 and extend to external port D. A fourth conduit 472 can extend between external port F and external port G, and can contain a second pressure sensor chamber 474. A fifth conduit 476 can extend from external port J to a first multivalve 478. A sixth conduit 480 can extend from first multivalve 478 to the fourth intra-manifold port 446, and can contain a third pressure sensor chamber 482. A seventh conduit 484 can extend from eighth intra-manifold port 454 to external port M, and can include a fourth pressure sensor chamber 486. An eighth conduit 488 can extend from external port E to sixth intra-manifold port 450. A ninth conduit 490 can extend from second intra-manifold port 442 to a second multivalve 492, and can include a fifth pressure sensor chamber 494. A tenth conduit 496 can extend from second multivalve 492 to external port H. An eleventh conduit 498 can extend from external port B to a third multivalve 500. A twelfth conduit 502 can connect third multivalve 500 to first multivalve 478, and a thirteenth conduit 504 can connect second and third multivalves 492, 500 respectively. A fourteenth conduit 506 can extend from external port L to seventh intra-manifold port 452. A fifteenth conduit 508 can extend from third intra-manifold port 444 to external port K. While certain conduits are described as containing a pressure sensor chamber, any conduit can contain any number of pressure sensor chambers. Each pressure sensor chamber can be independently covered by the flexible sheet and be aligned with a pressure sensor on a dialysis machine housing to allow for pressure measurements of a fluid with a given conduit. The multivalves can also be covered by the flexible sheet and can be aligned with actuators on a dialysis machine housing, the actuators being configured to control the multivalves and flow through the multivalves.
  • FIG. 5 is a partial view of a dialysis machine 520 in accordance with the present invention. Dialysis machine 520 has a machine housing 522 to which first and second hinges 524, 526, respectively, are mounted. A door 528 is, in turn, mounted to these hinges. Door 528 is shown in an open position in FIG. 5, but can be closed and secured with a door lock that includes a door lock insert 530 attached to door 528, and a door lock receptacle 532 disposed in machine housing 522. A manifold receptacle 534 is mounted on machine housing 522 and is configured to receive a manifold, for example, manifold 410 shown in FIG. 4. First, second, third, and fourth peristaltic pumps 536, 538, 540, and 542, respectively, are inset in machine housing 522 and positioned to engage first, second, third, and fourth pump tubes or pump headers, for example, pump tubes 456, 458, 460, and 462, shown in FIG. 4, respectively. First, second, third, and fourth pump shoes 544, 546, 548, and 550, respectively, are mounted on the inside of door 528 and are configured to press first, second, third, and fourth pump tubes of a manifold against first, second, third, and fourth peristaltic pumps 536, 538, 540, and 542, respectively. A platen 552 is also mounted on the inside of door 528 and is configured to press a manifold, for example, manifold 410, shown in FIG. 4, into manifold receptacle 534.
  • First, second, third, fourth, and fifth pressure sensors 554, 556, 558, 560, and 562, respectively, are positioned on machine housing 522 within manifold receptacle 534 to engage first, second, third, fourth, and fifth pressure sensor chambers 466, 474, 482, 486, and 494, shown in FIG. 4, respectively. A first set of valve actuators 564 is positioned in machine housing 522 within manifold receptacle 534, to engage first multivalve 478 shown in FIG. 4. A second set of valve actuators 566 is positioned in machine housing 522 within manifold receptacle 534 to engage second multivalve 492 shown in FIG. 4. A third set of valve actuators 568 is positioned in machine housing 522 within manifold receptacle 534 to engage third multivalve 500 shown in FIG. 4. First and second air detectors 570, 572 are included in machine housing 522. A blood leak detector 574, an occlusion detector 576, and a bloodline clamp 578, are also included in machine housing 522.
  • FIG. 6 shows a schematic diagram of a hemodialysis system 610 that can utilize a suitable manifold, for example, manifold 410, the details of which are shown in FIG. 4. External tubes, preferably flexible, are used to connect the manifold via the external ports to other components of the dialysis system, such as a dialyzer 612, an anticoagulant source 614, a saline source 616, an electrolyte source 618, a sorbent cartridge 620, a dialysate source 622, and a dialysate reservoir 624. Collectively, the manifold, external tubes, and other dialysis system components can form one or more circuits, for example, an extracorporeal blood circuit and a dialysate circuit. One can appreciate that a given tube can be made of one or more shorter tubes joined together by one or more connectors.
  • As can be seen in FIG. 6, an extracorporeal blood circuit 626 is provided in the hemodialysis system shown. A first external tube 628 can extend from the patient, for example, an artery of the patient, to external port C. A second external tube 630 can extend from external port A to a first dialyzer port 632. A third external tube 634 can extend from a second dialyzer port 636 to external port G. A fourth external tube 638 can extend from external port F back to the patient, for example, to a vein of the patient. A fifth external tube 640 can connect anti-coagulant source 614 to the extracorporeal blood circuit 626, for example, at a first branch point 642 in second external tube 630. A sixth external tube 644 can connect saline source 616 to external port D.
  • With reference to FIGS. 4-6, blood can flow in extracorporeal blood circuit 626 in the following manner. The flow can be powered and controlled by first peristaltic pump 536, shown in FIG. 5, operatively associated with first pump tube 456, shown in FIG. 4. Blood can flow from the patient, for example, out of an artery, through first external tube 628, through second conduit 468, first pump tube 456, through first conduit 464, through second external tube 630, through dialyzer 612, through third external tube 634, through fourth conduit 472, through fourth external tube 638, and back to the patient, for example, into a vein of the patient. Anticoagulant can be supplied through fifth external tube 640 into extracorporeal blood circuit 626. A priming sequence can be used in extracorporeal blood circuit 626 by flowing saline from saline source 616 through external tube 644 and third conduit 470 into extracorporeal blood circuit 626, for example, at a location along second conduit 468.
  • A dialysate circuit 646 can also form part of hemodialysis system 610. A seventh external tube 648 can extend from a dialysate or water source 622 to external port J. An eighth external tube 650 can extend from external port M to a first sorbent cartridge port 652. A ninth external tube 654 can extend from a second sorbent cartridge port 656 to an ammonia sensor 658. A tenth external tube 660 can extend from ammonia sensor 658 to dialysate reservoir 624. An eleventh external tube 662 can extend from dialysate reservoir 624 to external port E. A twelfth external tube 664 can extend from external port H to a third dialyzer port 665. A thirteenth external tube 668 can extend from a fourth dialyzer port 670 to external port B. A fourteenth external tube 672 can extend from electrolyte source 618 to external valve port L. A fifteenth external tube 674 can extend from external port K to a second branch point 676 in eleventh external tube 662.
  • As can be seen in FIGS. 4-6, dialysate can flow through dialysate circuit 646, which can be powered by second and fourth peristaltic pumps 538, 542, respectively, shown in FIG. 5, which are in operative association with second and fourth pump tubes 458, 462, respectively, shown in FIG. 4. Third peristaltic pump 540 can be in operative association with third pump tube 460 to allow a flow of electrolytes to enter dialysate circuit 646. Dialysate, or water, can flow from dialysate source 622 through seventh external tube 648, fifth conduit 476, sixth conduit 480, fourth pump tube 462, seventh conduit 484, eighth external tube 650, sorbent cartridge 620, ninth external tube 654, ammonia sensor 658, tenth external tube 660, dialysate reservoir 624, eleventh external tube 662, eighth conduit 488, second pump tube 458, ninth conduit 490, tenth conduit 496, twelfth external tube 664, dialyzer 612, thirteenth external tube 668, eleventh conduit 498, twelfth conduit 502, and back to sixth conduit 480, to complete dialysate circuit 646. Electrolytes can flow through fourteenth external tube 672, fourteenth conduit 506, pump tube 460, fifteen conduit 508, and into dialysis circuit 646, for example, at second branch point 676 along eleventh external tube 662.
  • FIG. 7A shows a hemodiafiltration system 710 that represents a significant advancement over hemodialysis system 610 shown in FIG. 6. A sixteenth external tube 712 replaces external tube 664 and is placed in fluidic communication with both extracorporeal blood circuit 626 and dialysate circuit 646. Sixteenth external tube 712 is shown in greater detail in FIG. 7B. Sixteenth external tube 712 can link dialysate circuit 646 to first and/or second external tubes 628, 630 on an arterial side of the extracorporeal blood circuit. Alternatively, or additionally, sixteenth external tube 712 can join dialysate circuit 646 and third and/or fourth external tubes 634 and/or 638, respectively, on the venous side of extracorporeal blood circuit 626. The dialysate flow can originate from a main segment 714 and be split between a first branch segment 716 and a second branch segment 718.
  • The proportion of dialysate remaining in dialysate circuit 646 to that entering extracorporeal blood circuit 626 in hemodiafiltration system 710 can be controlled by any suitable mechanism. For example, one or more flow restrictors can be used. A flow restrictor can be located in and/or on at least one of first branch segment 716 and second branch segment 718. For example, a first flow restrictor 720 can be located in and/or on first branch segment 716 and a second flow restrictor 722 can be located in and/or on second branch segment 718. A flow restrictor can have a defined or a variable restriction. A flow restrictor can be formed as part of the external tube. A flow restrictor can be distinct from, but operatively connectable to, the external tube. A flow restrictor can be provided on a dialysis machine housing and be configured to accept an external tube. Any suitable flow restrictor can be used. For example, a flow restrictor can be clipped on the outside of the external tube. One or more valve can act as a flow restrictor. One or more additional pumps and/or valves can be used in place of or in addition to the at least one flow restrictor. For example, a two-way valve that opens and closes periodically can be used to achieve a diversion of flow. Flow diversion can be achieved by simply using a branched external line independent of any induced restriction.
  • Sixteenth external tube 712 can contain one or more bacterial filter in parallel and/or in series with one another. Any suitable number or type of bacterial filter can be used. The at least one bacterial filter can be placed at any suitable location. For example, FIGS. 7A and 7B show a first bacterial filter 724 and a second bacterial filter 726 in second branch segment 718. A bacterial filter can also act as or as part of a flow restrictor.
  • FIG. 8 is a schematic flow diagram of hemodiafiltration system 710 shown in FIG. 7A, which also refers to elements identified in FIGS. 4-6. Blood can be pumped, from a patient 611, by first peristaltic pump 536 and be made to flow through extracorporeal blood circuit 626, through occlusion detector 576, through first pressure sensor chamber 466, through dialyzer 612, through second pressure sensor chamber 474, through second air detector 572, through pinch valve 573, and back to patient 611. An anticoagulant source 614 can be used to add anticoagulant into extracorporeal blood circuit 646. Saline source 616 can be used to prime extracorporeal blood circuit 626. Dialysate can be pumped into dialysate circuit 646 by second and fourth peristaltic pumps, 538 and 542 respectively, through first multivalve 478, through third pressure sensor chamber 482, through fourth pressure sensor chamber 486, through sorbent cartridge 620, through ammonia sensor 658, through dialysate reservoir 624, through fifth pressure sensor 494, and through second multivalve 492. After passing through second multivalve 492 and into sixteenth external tube 712, the dialysate can flow into first branch segment 716 and/or second branch segment 718, which can be controlled by first and/or second flow restrictors 720 and/or 722, respectively. Dialysate flowing through second branch segment 718 can flow through first and second bacterial filters 724, 726, before flowing into extracorporeal blood circuit 626. Electrolytes can be pumped from electrolyte source 618 that can be monitored with a level sensor 619. The electrolytes can be pumped, using a third peristaltic pump 540, into dialysate circuit 646. Dialysate in dialysate reservoir 624 can be weighed by a scale 623 and heated using heater/thermistors 625.
  • Switching between a hemodialysis mode and a hemodiafiltration mode can be achieved by switching between appropriate sets of disposables, although the core manifold design can be maintained in both modes. A switch to or from a peritoneal dialysis mode can be similarly accomplished in accordance with the present invention. A switch between a hemodialysis mode and a hemodiafiltration mode can also be achieved by using the same set of disposables together with a complete restriction and or valve rerouting of circuit flows.
  • The present invention includes the following aspects/embodiments/features in any order and/or in any combination:
  • 1. A manifold comprising:
  • a manifold body comprising
      • at least one conduit comprising a first conduit
      • at least one port comprising a first port in fluid communication with the first conduit;
  • an external tube in fluid communication with the first port and comprising
      • a main segment,
      • a first branch segment comprising a first flow restrictor, and
      • a second branch segment comprising a second flow restrictor and at least one bacterial filter,
  • wherein the second flow restrictor is located between the at least one bacterial filter and the main segment.
  • 2. The manifold of any preceding or following embodiment/feature/aspect, wherein the second branch segment comprises at least two bacterial filters.
    3. The manifold of any preceding or following embodiment/feature/aspect, further comprising a dialyzer in fluid communication with the first branch segment.
    4. The manifold of any preceding or following embodiment/feature/aspect, wherein at least one of the first and second flow restrictors comprises a static flow restrictor.
    5. The manifold of any preceding or following embodiment/feature/aspect, wherein the manifold is configured to engage a dialysis machine and the first conduit is configured to join a first circuit.
    6. The manifold of any preceding or following embodiment/feature/aspect, wherein the dialysis machine comprises at least one pump and the manifold is configured to engage the at least one pump to allow for movement of a first fluid through the first circuit.
    7. The manifold of any preceding or following embodiment/feature/aspect, wherein the at least one pump comprises a peristaltic pump.
    8. The manifold of any preceding or following embodiment/feature/aspect, wherein the manifold comprises a second conduit configured to join a second circuit.
    9. The manifold of any preceding or following embodiment/feature/aspect, wherein the dialysis machine comprises a second pump and the manifold is configured to engage the second pump to allow for movement of a second fluid in the second circuit.
    10. The manifold of any preceding or following embodiment/feature/aspect, wherein the external tube is in fluid communication with the first and second conduits.
    11. The manifold of any preceding or following embodiment/feature/aspect, wherein the second branch segment comprises a valve between the at least one bacterial filter and the main segment.
    12. The manifold of any preceding or following embodiment/feature/aspect, wherein the first circuit is a dialysate circuit and the second circuit is an extracorporeal blood circuit.
    13. A kit comprising the manifold of any preceding or following embodiment/feature/aspect and a dialyzer.
    14. A dialysis machine comprising:
  • a housing;
  • a receptacle mounted on the housing and configured to accept the manifold of any preceding or following embodiment/feature/aspect; and
  • the manifold of any preceding or following embodiment/feature/aspect operatively engaged with the receptacle.
  • 15. A dialysis system comprising:
  • the dialysis machine of any preceding or following embodiment/feature/aspect; and
  • a supply of dialysate in fluid communication with the manifold;
  • wherein the dialysis system is configured to perform hemodiafiltration.
  • 16. A dialysis machine comprising:
  • a housing;
  • a receptacle mounted on the housing and configured to accept a manifold
  • the manifold operatively engaged with the receptacle, the manifold comprising
      • a manifold body comprising
        • at least one conduit comprising a first conduit
        • at least one port comprising a first port in fluid communication
      • with the first conduit;
        • an external tube in fluid communication with the first port and comprising
          • a main segment,
          • a first branch segment, and
          • a second branch segment comprising at least one bacterial filter; and
  • at least one flow restrictor mounted on the housing and configured for accepting at least one of the first branch segment and the second branch segment.
  • 17. The dialysis machine of any preceding or following embodiment/feature/aspect, wherein the at least one flow restrictor comprises a first flow restrictor configured to receive the first branch segment and a second flow restrictor configured to receive the second branch segment.
    18. The dialysis machine of any preceding or following embodiment/feature/aspect, wherein the at least one flow restrictor comprises a static flow restrictor.
    19. The dialysis machine of any preceding or following embodiment/feature/aspect, wherein the at least one flow restrictor comprises a dynamic flow restrictor.
    20. A dialysis system comprising:
  • the dialysis machine of any preceding or following embodiment/feature/aspect; and
  • a supply of dialysate in fluid communication with the manifold;
  • wherein the dialysis system is configured to perform hemodiafiltration.
  • 21. A manifold comprising:
  • a manifold body comprising
      • a first transom comprising a first edge, and second and third edges substantially parallel to the first edge,
      • a trunk substantially perpendicular to and adjacent the first transom,
      • a second transom comprising a fourth edge, and fifth and sixth edges substantially parallel to the first, second, and third edges, the second transom being substantially perpendicular to and adjacent the trunk and substantially parallel to the first transom;
  • a plurality of ports arrayed along the fourth edge, and comprising
      • at least a first port and a second port,
      • a third port located on the second edge, and
      • a fourth port located on the fifth edge;
  • a first conduit in the second transom and in fluid communication with the first and fourth ports,
  • a second conduit in the first transom and in fluid communication with the second and third ports;
  • a first pump tube in fluid communication with the third and fourth ports; and
  • a first external tube in fluid communication with the second port and comprising
      • a main segment,
      • a first branch segment, and
      • a second branch segment.
        22. The manifold of any preceding or following embodiment/feature/aspect, wherein at least one of the first branch segment and the second branch segment comprises a flow restrictor.
        23. The manifold of any preceding or following embodiment/feature/aspect, wherein the first branch segment comprises a first flow restrictor and the second branch segment comprises a second flow restrictor.
        24. The manifold of any preceding or following embodiment/feature/aspect, wherein the flow restrictor is a static flow restrictor.
        25. The manifold of any preceding or following embodiment/feature/aspect, wherein the second branch segment comprises at least one bacterial filter.
        26. The manifold of any preceding or following embodiment/feature/aspect, wherein the second branch segment comprises a valve between the at least one bacterial filter and the main segment.
        27. The manifold of any preceding or following embodiment/feature/aspect, further comprising a dialyzer in fluid communication with the first branch segment.
        28. The manifold of any preceding or following embodiment/feature/aspect, wherein the manifold is configured to engage a dialysis machine and the first conduit is configured to join a first circuit.
        29. The manifold of any preceding or following embodiment/feature/aspect, wherein the dialysis machine comprises at least one pump and the manifold is configured to engage the at least one pump with the first pump tube to allow for a movement of a first fluid in the first circuit.
        30. The manifold of any preceding or following embodiment/feature/aspect, wherein the at least one pump comprises a peristaltic pump.
        31. The manifold of any preceding or following embodiment/feature/aspect, wherein the manifold comprises a second pump tube in fluid communication with a fifth port on the second edge and a sixth port on the fifth edge, the second pump tube being configured to join a second circuit, wherein the dialysis machine comprises a second pump and the manifold is configured to engage the second pump with the second pump tube to allow for movement of a second fluid through the second circuit.
        32. The manifold of any preceding or following embodiment/feature/aspect, wherein the external tube is in fluid communication with the first and second circuits.
        33. The manifold of any preceding or following embodiment/feature/aspect, wherein the first circuit is a dialysate circuit and the second circuit is an extracorporeal blood circuit.
        34. A kit comprising:
  • the manifold of any preceding or following embodiment/feature/aspect,
  • a dialyzer; and
  • a bacterial filter.
  • 35. A dialysis system comprising:
  • a dialysis machine;
  • the manifold of any preceding or following embodiment/feature/aspect operatively engaged with the dialysis machine; and
  • a supply of dialysate in fluid communication with the manifold;
  • wherein the second branch segment comprises at least one bacterial filter and the dialysis system is configured to perform hemodiafiltration.
  • 36. A method of performing hemodiafiltration on a patient comprising:
  • pumping a flow of dialysate through a dialysate circuit;
  • pumping a flow of blood through an extracorporeal blood circuit;
  • restricting the flow of dialysate in the dialysate circuit to divert a portion of the flow of dialysate into the extracorporeal blood circuit; and
  • passing the portion through at least one bacterial filter before the portion enters the blood circuit.
  • 37. The method of any preceding or following embodiment/feature/aspect, wherein the flow restriction is static.
    38. The method of any preceding or following embodiment/feature/aspect, wherein the flow restriction is varied.
    39. The method of any preceding or following embodiment/feature/aspect, wherein the dialysate circuit comprises a branched conduit comprising a main segment, a first branch segment, and a second branch segment, wherein the second branch segment carries the portion and is in fluid communication with the extracorporeal blood circuit and the restricting comprises restricting the flow of dialysate in at least one of the first branch segment and the second branch segment.
    40. The method of any preceding or following embodiment/feature/aspect, wherein the restricting comprises restricting the flow of dialysate in both the first branch segment and the second branch segment.
    41. The method of any preceding or following embodiment/feature/aspect, wherein at least one of the flow of dialysate and the flow of blood is pumped through a manifold engaged with a dialysis machine.
    42. The method of any preceding or following embodiment/feature/aspect, further comprising engaging the manifold with the dialysis machine.
    43. The method of any preceding or following embodiment/feature/aspect, wherein at least one of the pumping the flow of dialysate and the pumping the flow of blood comprises pumping with at least one peristaltic pump.
    44. The method of any preceding or following embodiment/feature/aspect, wherein the dialysate circuit comprises a sorbent cartridge capable of regenerating the dialysate.
    45. The method of any preceding or following embodiment/feature/aspect, further comprising pumping an electrolyte solution into the dialysate circuit.
    46. The method of any preceding or following embodiment/feature/aspect, wherein the pumping of the flow of dialysate and the pumping of the flow of blood comprises pumping through at least one dialyzer.
    47. The method of any preceding or following embodiment/feature/aspect, wherein the at least one bacterial filter comprises at least one dialyzer.
    48. The method of any preceding or following embodiment/feature/aspect, wherein the extracorporeal circuit comprises an arterial side and a venous side and the portion is diverted into at least one of the arterial side and the venous side.
    49. The method of any preceding or following embodiment/feature/aspect, wherein the portion is diverted into the arterial side.
    50. The method of any preceding or following embodiment/feature/aspect, further comprising measuring a central venous pressure of the patient.
    51. The method of any preceding or following embodiment/feature/aspect, wherein the flow restriction is varied depending on the central venous pressure measured.
    52. The method of any preceding or following embodiment/feature/aspect, further comprising determining a target volume of fluid to be added or removed from the patient.
    53. The method of any preceding or following embodiment/feature/aspect, wherein the flow restriction is varied to add or remove the target volume.
  • The entire contents of all references cited in this disclosure are incorporated herein in their entireties, by reference. Further, when an amount, concentration, or other value or parameter is given as either a range, preferred range, or a list of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. Where a range of numerical values is recited herein, unless otherwise stated, the range is intended to include the endpoints thereof, and all integers and fractions within the range. It is not intended that the scope of the invention be limited to the specific values recited when defining a range.
  • Other embodiments of the present invention will be apparent to those skilled in the art from consideration of the present specification and practice of the present invention disclosed herein. It is intended that the present specification and examples be considered as exemplary only with a true scope and spirit of the invention being indicated by the following claims and equivalents thereof.

Claims (19)

1-35. (canceled)
36. A method of performing hemodiafiltration on a patient comprising:
pumping a flow of dialysate through a dialysate circuit;
pumping a flow of blood through an extracorporeal blood circuit;
restricting the flow of dialysate in the dialysate circuit to divert a portion of the flow of dialysate into the extracorporeal blood circuit; and
passing the portion through at least one bacterial filter before the portion enters the blood circuit.
37. The method of claim 36, wherein the flow restriction is static.
38. The method of claim 36, wherein the flow restriction is varied.
39. The method of claim 36, wherein the dialysate circuit comprises a branched conduit comprising a main segment, a first branch segment, and a second branch segment, wherein the second branch segment carries the portion and is in fluid communication with the extracorporeal blood circuit and the restricting comprises restricting the flow of dialysate in at least one of the first branch segment and the second branch segment.
40. The method of claim 39, wherein the restricting comprises restricting the flow of dialysate in both the first branch segment and the second branch segment.
41. The method of claim 36, wherein at least one of the flow of dialysate and the flow of blood is pumped through a manifold engaged with a dialysis machine.
42. The method of claim 41, further comprising engaging the manifold with the dialysis machine.
43. The method of claim 36, wherein at least one of the pumping the flow of dialysate and the pumping the flow of blood comprises pumping with at least one peristaltic pump.
44. The method of claim 36, wherein the dialysate circuit comprises a sorbent cartridge capable of regenerating the dialysate.
45. The method of claim 36, further comprising pumping an electrolyte solution into the dialysate circuit.
46. The method of claim 36, wherein the pumping of the flow of dialysate and the pumping of the flow of blood comprises pumping through at least one dialyzer.
47. The method of claim 36, wherein the at least one bacterial filter comprises at least one dialyzer.
48. The method of claim 36, wherein the extracorporeal circuit comprises an arterial side and a venous side and the portion is diverted into at least one of the arterial side and the venous side.
49. The method of claim 48, wherein the portion is diverted into the arterial side.
50. The method of claim 36, further comprising measuring a central venous pressure of the patient.
51. The method of claim 50, wherein the flow restriction is varied depending on the central venous pressure measured.
52. The method of claim 51, further comprising determining a target volume of fluid to be added or removed from the patient.
53. The method of claim 52, wherein the flow restriction is varied to add or remove the target volume.
US13/828,240 2013-03-14 2013-03-14 Universal portable machine for online hemodiafiltration using regenerated dialysate Abandoned US20140263062A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/828,240 US20140263062A1 (en) 2013-03-14 2013-03-14 Universal portable machine for online hemodiafiltration using regenerated dialysate

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US13/828,240 US20140263062A1 (en) 2013-03-14 2013-03-14 Universal portable machine for online hemodiafiltration using regenerated dialysate
CA2899641A CA2899641C (en) 2013-03-14 2014-03-13 Universal portable machine for online hemodiafiltration using regenerated dialysate
EP14714551.0A EP2968726A1 (en) 2013-03-14 2014-03-13 Universal portable machine for online hemodiafiltration using regenerated dialysate
CN201480014881.0A CN105102013B (en) 2013-03-14 2014-03-13 The portable device using a universal regenerated dialysate with online hemodiafiltration
MX2015009231A MX2015009231A (en) 2013-03-14 2014-03-13 Universal portable machine for online hemodiafiltration using regenerated dialysate.
PCT/US2014/025469 WO2014151322A1 (en) 2013-03-14 2014-03-13 Universal portable machine for online hemodiafiltration using regenerated dialysate
US14/958,335 US20160089485A1 (en) 2013-03-14 2015-12-03 Universal portable machine for online hemodiafiltration using regenerated dialysate
HK16100722.7A HK1212929A1 (en) 2013-03-14 2016-01-22 Universal portable machine for online hemodiafiltration using regenerated dialysate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/958,335 Continuation US20160089485A1 (en) 2013-03-14 2015-12-03 Universal portable machine for online hemodiafiltration using regenerated dialysate

Publications (1)

Publication Number Publication Date
US20140263062A1 true US20140263062A1 (en) 2014-09-18

Family

ID=50397353

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/828,240 Abandoned US20140263062A1 (en) 2013-03-14 2013-03-14 Universal portable machine for online hemodiafiltration using regenerated dialysate
US14/958,335 Pending US20160089485A1 (en) 2013-03-14 2015-12-03 Universal portable machine for online hemodiafiltration using regenerated dialysate

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/958,335 Pending US20160089485A1 (en) 2013-03-14 2015-12-03 Universal portable machine for online hemodiafiltration using regenerated dialysate

Country Status (7)

Country Link
US (2) US20140263062A1 (en)
EP (1) EP2968726A1 (en)
CN (1) CN105102013B (en)
CA (1) CA2899641C (en)
HK (1) HK1212929A1 (en)
MX (1) MX2015009231A (en)
WO (1) WO2014151322A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150190809A1 (en) * 2012-07-23 2015-07-09 EMD Millpore Corporation Device For A Biological Liquid Treatment Installation
US9433720B2 (en) 2013-03-14 2016-09-06 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US9523072B2 (en) 2009-01-23 2016-12-20 Emd Millipore Corporation Method for providing a circuit for biological liquid and circuit obtained
WO2017112776A1 (en) 2015-12-21 2017-06-29 Fresenius Medical Care Holdings, Inc. Modula blood treatment systems, units, and methods
US9739424B2 (en) 2010-06-08 2017-08-22 Emd Millipore Corporation Device for a biological liquid treatment installation
US9744487B2 (en) 2010-06-08 2017-08-29 Emd Millipore Corporation Device for a biological liquid treatment installation
US9777847B2 (en) 2012-07-23 2017-10-03 Emd Millipore Corporation Circuit for biological liquid comprising a pinch valve

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5730712A (en) * 1994-01-17 1998-03-24 Althin Medical, Inc. Extracorporeal blood treatment apparatus and method
US6303036B1 (en) * 1998-07-31 2001-10-16 Nephros, Inc. Method and apparatus for efficient hemodiafiltration
US20040019312A1 (en) * 2002-07-19 2004-01-29 Childers Robert W. Systems and methods for performing peritoneal dialysis
US20050131331A1 (en) * 2003-12-16 2005-06-16 Kelly Thomas D. Medical fluid therapy flow control systems and methods
US20090124963A1 (en) * 2007-11-09 2009-05-14 Baxter International Inc. Balanced flow dialysis machine
US20100116740A1 (en) * 2007-11-29 2010-05-13 Barry Neil Fulkerson Priming System and Method for Dialysis Systems
US20100331754A1 (en) * 2007-09-28 2010-12-30 Fresenius Medical Care Holding Method and Systems for Controlling Ultrafiltration Using Central Venous Pressure Measurements
US20110009798A1 (en) * 2003-11-05 2011-01-13 Baxter International Inc. Renal therapy system having pump reversing fluid control
US20110315611A1 (en) * 2007-09-13 2011-12-29 Barry Neil Fulkerson Portable Dialysis Machine

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2239254C2 (en) 1970-12-30 1983-08-04 Organon Teknika Corp., Oklahoma City, Okla., Us
DE2542438C3 (en) 1975-09-24 1981-01-22 Dr. Eduard Fresenius Chemisch-Pharmazeutische Industrie Kg Apparatebau Kg, 6380 Bad Homburg
US4037596A (en) 1975-12-03 1977-07-26 Burron Medical Products, Inc. Parenteral administration set with internal valve and flow restrictor
NL7703937A (en) 1977-04-12 1978-10-16 Organon Teknika Bv The device is provided with a sorbent for the purification of blood; a sorbent suitable for oral use and a process for manufacture of the sorbent.
DE2721444A1 (en) 1977-05-12 1978-11-16 Fresenius Chem Pharm Ind hollow fiber dialyzer
US4190047A (en) 1977-08-26 1980-02-26 University Of Utah Method and apparatus for peritoneal dialysis
DE2847945C2 (en) 1978-11-04 1984-01-12 Fresenius Ag, 6380 Bad Homburg, De
US4247393A (en) 1979-01-11 1981-01-27 Wallace Richard A Hemodialysis assist device
US4267834A (en) 1979-04-24 1981-05-19 American Hospital Supply Corporation System for flushing a medical fluid
US4464179A (en) 1981-03-20 1984-08-07 American Hospital Supply Corporation Medical flushing valve
US4311587A (en) 1979-12-10 1982-01-19 Japan Foundation For Artificial Organs Filter arrangement denying bacteria entry to peritoneum
US4347136A (en) 1981-02-18 1982-08-31 Neil Friesen Bacteria static filter assembly
US4568366A (en) 1983-08-30 1986-02-04 Baxter Laboratories, Inc. In-line filter
US4661246A (en) 1984-10-01 1987-04-28 Ash Medical Systems, Inc. Dialysis instrument with dialysate side pump for moving body fluids
US4626243A (en) 1985-06-21 1986-12-02 Applied Biomedical Corporation Gravity-independent infusion system
US5248300A (en) 1991-12-16 1993-09-28 Abbott Laboratories Ambulatory infusion system with spring-pressurized reservoir
US5536412A (en) 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5919369A (en) 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5277820A (en) 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
CN1058193C (en) * 1992-03-15 2000-11-08 彭罗民 Will move artificial kidney
US5282981A (en) 1992-05-01 1994-02-01 E. I. Du Pont De Nemours And Company Flow restrictor-separation device
US6156007A (en) 1992-09-04 2000-12-05 Hemotherm, Inc. Apparatus for whole-body hyperthermia
US5409477A (en) 1993-09-23 1995-04-25 Abbott Laboratories Solution administration apparatus with orifice flow control device
US5944684A (en) 1995-08-31 1999-08-31 The Regents Of The University Of California Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications
US5769811A (en) * 1995-10-31 1998-06-23 Haemonetics Corporation Blood-processing machine system
US5868933A (en) 1995-12-15 1999-02-09 Patrick; Gilbert Antimicrobial filter cartridge
DE19607162C2 (en) 1996-02-26 1998-01-15 Fresenius Ag Use of a dialyzer with two modules for implementing a method for filtering and immediate use in a substituate Hämodialfiltrationsvorrichtung
US20010037964A1 (en) 1998-03-25 2001-11-08 Jay Won Filter system
DE19832451C1 (en) * 1998-07-18 1999-08-26 Fresenius Medical Care De Gmbh Method of checking the orderly exchange of a used filter in an arrangement for extracorporal blood treatment
US6331252B1 (en) * 1998-07-31 2001-12-18 Baxter International Inc. Methods for priming a blood compartment of a hemodialyzer
US6139739A (en) 1998-10-08 2000-10-31 Cuno Incorporated Composite filter element
CN1213769C (en) 1999-07-21 2005-08-10 宝洁公司 Microorganism filter and method for removing microorganism from water
US6655207B1 (en) 2000-02-16 2003-12-02 Honeywell International Inc. Flow rate module and integrated flow restrictor
DE10007327A1 (en) 2000-02-17 2001-08-30 Fresenius Medical Care De Gmbh Filter device, preferably hollow fiber dialyzer with hollow fibers curly
AT419024T (en) 2000-10-12 2009-01-15 Renal Solutions Inc Apparatus for controlling the flow of body fluids in extracorporeal treatment liquid
US7033498B2 (en) 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
DE10114283C2 (en) 2000-12-22 2003-04-24 Fresenius Medical Care De Gmbh A method for determining the ion concentration of the blood of a patient in citrate-anticoagulated hemodialysis and / or hemofiltration; dialysis machine
BR0207303A (en) * 2001-02-07 2004-06-15 Nephros Inc Method and apparatus for hemodiafiltration delivery module
US20030098276A1 (en) 2001-07-10 2003-05-29 Carlson Robert A. Filter for removing bacteria and particulates from fluid stream
US7615152B2 (en) 2001-08-23 2009-11-10 Pur Water Purification Products, Inc. Water filter device
KR100777951B1 (en) 2001-08-23 2007-11-28 더 프록터 앤드 갬블 캄파니 Water filter materials, corresponding water filters and processes for using the same
US20050279696A1 (en) 2001-08-23 2005-12-22 Bahm Jeannine R Water filter materials and water filters containing a mixture of microporous and mesoporous carbon particles
US6802821B2 (en) 2001-10-01 2004-10-12 Fresenius Usa, Inc. Dialyzer
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US6960179B2 (en) 2001-11-16 2005-11-01 National Quality Care, Inc Wearable continuous renal replacement therapy device
US20030114787A1 (en) 2001-12-13 2003-06-19 Victor Gura Wearable peritoneal dialysis system
US7182858B2 (en) 2003-03-04 2007-02-27 Kinetico Incorporated Multiple barrier filter apparatus
DK1523351T3 (en) 2002-07-19 2010-04-26 Baxter Int System for peritoneal dialysis
ES2366781T3 (en) 2002-07-19 2011-10-25 Baxter Healthcare S.A. Systems and methods for peritoneal dialysis.
US7018327B1 (en) 2002-08-27 2006-03-28 Conti James C Test apparatus providing pulsatile flow service for test samples
US20040116905A1 (en) 2002-09-09 2004-06-17 Pedersen Per Elgard Flow restrictor with safety feature
US6892755B2 (en) 2003-02-28 2005-05-17 Baxter International Inc. Pressure regulator for infusor
US6989101B2 (en) 2003-04-04 2006-01-24 The Clorox Company Microorganism-removing filter medium having high isoelectric material and low melt index binder
US7303683B2 (en) 2003-04-04 2007-12-04 The Clorox Company Microorganism-removing filter medium having high isoelectric material and low melt index binder
NL1023332C2 (en) 2003-05-02 2004-11-03 Norit Proces Technologie Holdi Membrane filter with ventilation and method for the production thereof.
US7169303B2 (en) 2003-05-28 2007-01-30 Hemocleanse Technologies, Llc Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
CN2746916Y (en) * 2004-12-01 2005-12-21 上海日科贸易有限公司 Blood purification equipment with concentration and filtration functions
JP5328152B2 (en) 2004-12-28 2013-10-30 レナル ソリューションズ,インク. Synthesis method of zirconium phosphate particles
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
DE102005029709B3 (en) 2005-06-24 2007-01-11 Fresenius Medical Care Deutschland Gmbh dialysis machine
RU2317843C2 (en) 2005-08-08 2008-02-27 Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) Filtering material, method of its manufacture and method of filtering
US7325572B2 (en) 2005-12-09 2008-02-05 Schinazi Robert G Flow restrictor device for a medical apparatus
RU2426561C2 (en) 2006-01-30 2011-08-20 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Methods and device for peritoneal dialysis
US8876753B2 (en) 2006-01-30 2014-11-04 The Regents Of The University Of California Peritoneal dialysis methods and apparatus
DE102006010813A1 (en) 2006-03-07 2007-09-13 Fresenius Medical Care Deutschland Gmbh Dialysis device with measuring devices for detecting blood pressure as well as methods for determining the blood pressure as well as a storage medium for use in a dialysis machine
US8715221B2 (en) * 2006-03-08 2014-05-06 Fresenius Medical Care Holdings, Inc. Wearable kidney
MXPA06005487A (en) 2006-05-15 2007-11-14 Whirlpool Mexico S A De C V Purified water filtration and dispensing system.
DK2040814T3 (en) 2006-06-14 2012-03-19 Aqua Nu Filtration Systems Ltd ceramic filter
US7690396B2 (en) 2006-07-20 2010-04-06 Baxter International Inc. Multirate tubing flow restrictor
US20080029173A1 (en) 2006-08-07 2008-02-07 Diperna Paul Mario Variable flow reshapable flow restrictor apparatus and related methods
WO2008075951A1 (en) 2006-12-21 2008-06-26 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Device for the removal of toxic substances from blood
KR101657569B1 (en) * 2007-10-12 2016-09-19 데카 프로덕츠 리미티드 파트너쉽 Apparatus and method for hemodialysis
US8529487B2 (en) * 2007-04-12 2013-09-10 Gambro Lundia Ab Method and apparatus for priming an extracorporeal blood circuit
JP2008303773A (en) 2007-06-07 2008-12-18 Hitachi Ltd Variable valve system of internal combustion engine
KR101475736B1 (en) * 2007-06-29 2014-12-24 삼성전자 주식회사 hand-writable electronic book
US20090076434A1 (en) 2007-09-13 2009-03-19 Mischelevich David J Method and System for Achieving Volumetric Accuracy in Hemodialysis Systems
US8105487B2 (en) 2007-09-25 2012-01-31 Fresenius Medical Care Holdings, Inc. Manifolds for use in conducting dialysis
US20090120864A1 (en) 2007-10-05 2009-05-14 Barry Neil Fulkerson Wearable dialysis methods and devices
US20090114037A1 (en) 2007-10-11 2009-05-07 Mark Forrest Smith Photo-Acoustic Flow Meter
NZ584767A (en) 2007-11-16 2012-06-29 Fresenius Med Care Hldg Inc Dialysis system with module having sodium control function
US8889004B2 (en) 2007-11-16 2014-11-18 Fresenius Medical Care Holdings, Inc. Dialysis systems and methods
WO2009073567A1 (en) 2007-11-29 2009-06-11 Xcorporeal. Inc. System and method for conducting hemodialysis and hemofiltration
US8220643B2 (en) 2008-06-06 2012-07-17 Fresenius Medical Care Holdings, Inc. Urea sorbent
RU2525205C2 (en) 2008-06-23 2014-08-10 Темасек Политехник Flow system of dialysis device and portable dialysis device
US7631562B1 (en) 2008-08-19 2009-12-15 Honeywell International Inc. Mass-flow sensor with a molded flow restrictor
US8409444B2 (en) 2008-09-30 2013-04-02 Fresenius Medical Care Holdings, Inc. Acid zirconium phosphate and alkaline hydrous zirconium oxide materials for sorbent dialysis
WO2010042667A2 (en) 2008-10-07 2010-04-15 Xcorporeal, Inc. Thermal flow meter
BRPI0921637A2 (en) 2008-10-30 2016-01-05 Fresenius Med Care Hldg Inc portable modular dialysis system
AU2009320025B2 (en) 2008-11-03 2013-02-28 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
US8240636B2 (en) 2009-01-12 2012-08-14 Fresenius Medical Care Holdings, Inc. Valve system
US20100184198A1 (en) 2009-01-16 2010-07-22 Joseph Russell T Systems and Methods of Urea Processing to Reduce Sorbent Load
US8535522B2 (en) 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
US8475399B2 (en) 2009-02-26 2013-07-02 Fresenius Medical Care Holdings, Inc. Methods and systems for measuring and verifying additives for use in a dialysis machine
WO2010114932A1 (en) 2009-03-31 2010-10-07 Xcorporeal, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US20100312174A1 (en) 2009-06-06 2010-12-09 Hoffman Josef C A Peritoneal Dialysis System
US20100312172A1 (en) 2009-06-06 2010-12-09 Hoffman Josef C A Method of Peritoneal Dialysis
US8080161B2 (en) 2009-06-11 2011-12-20 Baxter International Inc. Dialysis treatment devices for removing urea
EP3025739A1 (en) 2009-08-04 2016-06-01 Fresenius Medical Care Holdings, Inc. Dialysis systems, components, and methods
MX2012002599A (en) 2009-08-31 2012-04-02 Nestec Sa Cassette with infusion set containing spring-biased anti-freeflow mechanism for peristaltic infusion pump.
CN102596373A (en) 2009-10-29 2012-07-18 查尔斯斯塔克德雷珀实验室公司 Microfluidic device for blood dialysis
WO2011140268A2 (en) 2010-05-04 2011-11-10 C-Tech Biomedical, Inc. Dual mode hemodialysis machine
US20110313240A1 (en) 2010-06-21 2011-12-22 Cavu Medical, Inc. Flow restrictor and method for automatically controlling pressure for a gastric band
US8641659B2 (en) 2011-02-17 2014-02-04 Medtronic, Inc. Method and device to treat kidney disease
US20120265164A1 (en) 2011-04-14 2012-10-18 Medtronic, Inc. Flow restrictor for medical devices
US9320842B2 (en) 2011-04-29 2016-04-26 Medtronic, Inc. Multimodal dialysis system
DE102011106248A1 (en) 2011-07-01 2013-01-03 Fresenius Medical Care Deutschland Gmbh Container, use, dialysis machine or preparation unit and method for producing a concentrate
CN102389594B (en) * 2011-08-04 2014-04-30 黄昱 Portable blood purifying system

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5730712A (en) * 1994-01-17 1998-03-24 Althin Medical, Inc. Extracorporeal blood treatment apparatus and method
US6303036B1 (en) * 1998-07-31 2001-10-16 Nephros, Inc. Method and apparatus for efficient hemodiafiltration
US20040019312A1 (en) * 2002-07-19 2004-01-29 Childers Robert W. Systems and methods for performing peritoneal dialysis
US20110009798A1 (en) * 2003-11-05 2011-01-13 Baxter International Inc. Renal therapy system having pump reversing fluid control
US20050131331A1 (en) * 2003-12-16 2005-06-16 Kelly Thomas D. Medical fluid therapy flow control systems and methods
US20110315611A1 (en) * 2007-09-13 2011-12-29 Barry Neil Fulkerson Portable Dialysis Machine
US20100331754A1 (en) * 2007-09-28 2010-12-30 Fresenius Medical Care Holding Method and Systems for Controlling Ultrafiltration Using Central Venous Pressure Measurements
US20090124963A1 (en) * 2007-11-09 2009-05-14 Baxter International Inc. Balanced flow dialysis machine
US20100116740A1 (en) * 2007-11-29 2010-05-13 Barry Neil Fulkerson Priming System and Method for Dialysis Systems

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9523072B2 (en) 2009-01-23 2016-12-20 Emd Millipore Corporation Method for providing a circuit for biological liquid and circuit obtained
US9528085B2 (en) 2009-01-23 2016-12-27 Emd Millipore Corporation Method for providing a circuit for biological liquid and circuit obtained
US10195605B2 (en) 2009-01-23 2019-02-05 Emd Millipore Corporation Method for providing a circuit for biological liquid and circuit obtained
US9739424B2 (en) 2010-06-08 2017-08-22 Emd Millipore Corporation Device for a biological liquid treatment installation
US9744487B2 (en) 2010-06-08 2017-08-29 Emd Millipore Corporation Device for a biological liquid treatment installation
US9777847B2 (en) 2012-07-23 2017-10-03 Emd Millipore Corporation Circuit for biological liquid comprising a pinch valve
US20150190809A1 (en) * 2012-07-23 2015-07-09 EMD Millpore Corporation Device For A Biological Liquid Treatment Installation
US9259733B2 (en) * 2012-07-23 2016-02-16 Emd Millipore Corporation Device for a biological liquid treatment installation
US9433720B2 (en) 2013-03-14 2016-09-06 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
WO2017112776A1 (en) 2015-12-21 2017-06-29 Fresenius Medical Care Holdings, Inc. Modula blood treatment systems, units, and methods

Also Published As

Publication number Publication date
US20160089485A1 (en) 2016-03-31
WO2014151322A1 (en) 2014-09-25
CN105102013B (en) 2017-03-29
EP2968726A1 (en) 2016-01-20
CA2899641A1 (en) 2014-09-25
MX2015009231A (en) 2015-10-15
HK1212929A1 (en) 2016-06-24
CN105102013A (en) 2015-11-25
CA2899641C (en) 2018-01-02

Similar Documents

Publication Publication Date Title
JP6389219B2 (en) 3-fork reagent supply connector and 3-fork disinfection connector
CA2437090C (en) Method and apparatus for a hemodiafiltration delivery module
US6280632B1 (en) Device and method for preparation of substitution solution
JP6087892B2 (en) Dialysis system
EP0739234B1 (en) Hemofiltration and plasmafiltration device
US5919369A (en) Hemofiltration and plasmafiltration devices and methods
EP2368584B1 (en) Hemodialysis systems
US9744284B2 (en) Hybrid blood and peritoneal dialysis treatment systems and methods
EP2334412B1 (en) Priming system and method for dialysis systems
US4861485A (en) Hemodiafiltration device
ES2647775T3 (en) Hemodialysis system that has a flow path with a controlled distensible volume
US10363352B2 (en) Disposable set and system for dialysis
US20090101549A1 (en) Modular assembly for a portable hemodialysis system
JP2014061409A (en) Dialysis system
US20090114582A1 (en) Enclosure for a portable hemodialysis system
US20100056975A1 (en) Blood line connector for a medical infusion device
CN103842004B (en) Shuangliu sorbent cartridge
EP2744537B1 (en) Modular hemodialysis system
CN101711171B (en) Hemodialysis systems and methods
US9352282B2 (en) Manifolds for use in conducting dialysis
US20090105629A1 (en) Blood circuit assembly for a hemodialysis system
US8992463B2 (en) Balanced flow dialysis machine
US20090107335A1 (en) Air trap for a medical infusion device
JP5543049B2 (en) Method of operating blood purification apparatus and blood purification apparatus
EP2237814B1 (en) Manifold for conducting hemodialysis and hemofiltration

Legal Events

Date Code Title Description
AS Assignment

Owner name: FRESENIUS MEDICAL CARE HOLDINGS, INC., MASSACHUSET

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:UPDYKE, PALMER DAVID;FULKERSON, BARRY;DE LEON DE LEON, AMAURY;AND OTHERS;REEL/FRAME:030279/0546

Effective date: 20130404

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION